1. Home
  2. AUID vs SER Comparison

AUID vs SER Comparison

Compare AUID & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$0.96

Market Cap

35.6M

Sector

Technology

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.50

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
SER
Founded
2009
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
29.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AUID
SER
Price
$0.96
$2.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
388.8K
16.1K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,834,458.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
141.81
N/A
52 Week Low
$0.87
$2.37
52 Week High
$9.58
$7.92

Technical Indicators

Market Signals
Indicator
AUID
SER
Relative Strength Index (RSI) 32.48 29.35
Support Level $0.87 $2.46
Resistance Level $1.05 $4.26
Average True Range (ATR) 0.11 0.21
MACD 0.03 -0.02
Stochastic Oscillator 14.82 21.10

Price Performance

Historical Comparison
AUID
SER

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: